A Review of the Use of Infliximab to Manage Cutaneous Dermatoses

@article{Gupta2004ARO,
  title={A Review of the Use of Infliximab to Manage Cutaneous Dermatoses},
  author={A. Gupta and A. R. Skinner},
  journal={Journal of Cutaneous Medicine and Surgery: Incorporating Medical and Surgical Dermatology},
  year={2004},
  volume={8},
  pages={77-89}
}
  • A. Gupta, A. R. Skinner
  • Published 2004
  • Medicine
  • Journal of Cutaneous Medicine and Surgery: Incorporating Medical and Surgical Dermatology
  • BackgroundInfliximab is a chimeric monoclonal antibody that binds specifically to human tumor necrosis factor-alpha (TNF-α), decreasing the effect of the cytokine in inflammatory diseases.ObjectiveThe aim of this study was to review the efficacy and safety of infliximab in the treatment of dermatological diseases.MethodsA MEDLINE search (1966–January 2003), using the keyword “infliximab” was performed to find relevant articles pertaining to the use of infliximab in dermatology.ResultsInfliximab… CONTINUE READING
    56 Citations
    Lymphoedematous variants of Kaposi's sarcoma
    • L. Pantanowitz, W. Duke
    • Medicine
    • Journal of the European Academy of Dermatology and Venereology : JEADV
    • 2008
    • 21
    Infliximab in dermatological treatment: beyond psoriasis
    • 19
    Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis.
    • 51
    • PDF
    The use of infliximab in dermatology
    • S. Rott, U. Mrowietz
    • Medicine
    • Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
    • 2007
    • 15
    Infliximab and Golimumab
    Type III juvenile pityriasis rubra pilaris: a successful treatment with infliximab
    • 29
    [Efficacy of etanercept in the treatment of acne conglobata].
    • 3

    References

    SHOWING 1-10 OF 113 REFERENCES
    Behçet’s disease: a new target for anti-tumour necrosis factor treatment
    • P. Sfikakis
    • Medicine
    • Annals of the rheumatic diseases
    • 2002
    • 200
    • PDF